Pfizer Inc. PFE on Wednesday reported positive Phase 2 data for its investigational 25-valent pneumococcal conjugate vaccine candidate. The study showed strong immune responses in infants compared ...

New 25-strain Prevnar candidate moves into final-stage testing after strong infant trial results against severe pneumonia strain.

Just before 9:30 a.m. on Monday, Sandra Lindsay, an intensive care nurse at Long Island Jewish Medical Center in Queens, New York, became one of the first people to get vaccinated against COVID-19.

Pfizer PFE has committed significant resources toward the development of treatments in the fields of oncology, metabolic ...

A two-year-old did not die during Pfizer-BioNTech’s ongoing COVID-19 vaccine trial in kids under 12, contrary to claims on social media. An unverified entry saying so in the United States’ federal ...